SLC5A2 and hydrops fetalis: Similarly, a multimodality imaging study confirmed that empagliflozin reduces myocardial stiffness and fibrosis in HF patients, suggesting that SGLT2 inhibitors may enhance myocardial energetics and reduce oxidative stress [20, 24].